Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript

Theravance Biopharma, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.04.

Related Keywords

China ,London ,City Of ,United Kingdom ,United States ,Japan ,Rick Winningham ,Douglas Tsao ,Theravance Biopharma ,David Risinger ,Rhonda Farnum ,Aziz Sawaf ,Head Of Development ,Nasdaq ,Theravance Biopharma Inc ,National Institutes Of Health ,Department Of Neurosciences ,Call Transcript February ,Theravance Biopharma Fourth Quarter ,Chief Executive ,Raine Miller ,Chief Business Officer ,Chief Financial ,Inflation Reduction ,National Institutes ,Gold Report ,Best Paying Jobs ,Best Job ,